Propofol Sedation During Upper Endoscopy With and Without Topical Pharyngeal Anesthesia
Study of Propofol Sedation During Upper Endoscopy With and Without Topical Pharyngeal Anesthesia
1 other identifier
interventional
294
1 country
2
Brief Summary
It is unclear whether a topical pharyngeal anesthesia adds any benefit to the upper gastrointestinal endoscopy under a propofol sedation. We hypothesize that a topical pharyngeal anesthesia does not ease the upper gastrointestinal endoscopy under propofol sedation. The aim of this study is therefore to quantify the impact of a topical pharyngeal anesthesia to the upper gastrointestinal endoscopy in patients sedated with propofol. Patients will be randomized to receive a topical pharyngeal spray containing either an anesthetic drug (lidocaine 10%) or a placebo. Thereafter the upper endoscopy will be conducted in its standard manner.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Aug 2009
Shorter than P25 for phase_4
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2009
CompletedFirst Submitted
Initial submission to the registry
March 2, 2010
CompletedFirst Posted
Study publicly available on registry
March 5, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2010
CompletedDecember 3, 2014
March 1, 2010
9 months
March 2, 2010
December 2, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Number triggered gag reflex during the intubation of the endoscope
Start of the exam until the successful intubation of the esophagus with the endoscope
Number of attempts of intubation with the endoscope through the upper esophageal sphincter
Start of the exam until the successful intubation of the esophagus with the endoscope
Extent of salivation during intubation
Start of the exam until the successful intubation of the esophagus with the endoscope
Secondary Outcomes (8)
Amount of propofol used to successfully intubate the esophagus
Start of the exam until the successful intubation of the esophagus with the endoscope
Total amount of propofol used during the investigation
From the start until the end of the exam
Overall assessment of the procedure by the endoscopist
Immediately after finishing the endoscopy
Assumption of the endoscopist if lidocaine or placebo has been used
Immediately after finishing the endoscopy
Overall assessment of the investigation by the patient
Immediately after recovery of consciousness of the patient
- +3 more secondary outcomes
Study Arms (2)
Anesthesia (=A) with lidocaine 10%
ACTIVE COMPARATOR3 min before sedation 4 puffs of terbutaline diluted lidocaine solution (Xylocaine ® 10% spray, Astra Zeneca, London, UK) will be sprayed on the pharynx
A with diluted gentian root solution
PLACEBO COMPARATOR3 min before sedation 4 puffs of highly diluted gentian solution will be sprayed on the pharynx
Interventions
3 min before the endoscopy under propofol sedation 4 puffs of lidocaine 10% will be sprayed on the pharynx as a pharyngeal anesthesia
As a basis, an infusion of water (45%), ethanol (35%) and gentian root cut will be used. The gentian root infusion is approved as a natural flavor in the food industry.3 min before the endoscopy under propofol sedation 4 puffs of this gentian root infusion will be sprayed on the pharynx as a pharyngeal anesthesia
Eligibility Criteria
You may qualify if:
- Scheduled diagnostic upper endoscopy
- Wish to be sedated
- ASA class I - III
- Signed informed consent
You may not qualify if:
- Emergency medical examinations
- Therapeutic Endoscopy
- ASA class IV
- Pregnancy
- Known allergy to propofol or lidocaine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University Hospital; Division of Gastroenterology and Hepatology
Basel, Canton of Basel-City, 4031, Switzerland
Hospital of Zollikerberg, Internal Medicine
Zollikerberg, Canton of Zurich, 8125, Switzerland
Related Publications (1)
Heuss LT, Hanhart A, Dell-Kuster S, Zdrnja K, Ortmann M, Beglinger C, Bucher HC, Degen L. Propofol sedation alone or in combination with pharyngeal lidocaine anesthesia for routine upper GI endoscopy: a randomized, double-blind, placebo-controlled, non-inferiority trial. Gastrointest Endosc. 2011 Dec;74(6):1207-14. doi: 10.1016/j.gie.2011.07.072. Epub 2011 Oct 13.
PMID: 22000794DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ludwig T Heuss, MD
Spital Zollikerberg
- PRINCIPAL INVESTIGATOR
Lukas Degen, Prof
University Hospital, Basel, Switzerland
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof.
Study Record Dates
First Submitted
March 2, 2010
First Posted
March 5, 2010
Study Start
August 1, 2009
Primary Completion
May 1, 2010
Study Completion
May 1, 2010
Last Updated
December 3, 2014
Record last verified: 2010-03